Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse.

BMC Neurosci · 2010 · PMC2964735 · PMID 20946660

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

There was a slight trend toward lowered Aβ40/42 levels in FA-treated brain homogenates, and raised Aβ40/42 levels in DEA-treated brain homogenates for 6D11 treated Tg animals; however, the differences were not statistically significant.

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.